← Caregiver glossary · Medical concepts
The use of multiple medications by one patient — generally defined as 5+ regular medications. Increases drug-interaction risk, side-effect burden, adherence challenges, and cost. Common in older adults with multiple chronic conditions; each new medication should be weighed against what could come off.
Polypharmacy is the most common avoidable harm in older-adult care. About 40% of US adults 65+ take 5+ medications regularly; about 20% take 10+. Each additional medication increases the risk of drug interactions, adverse drug events, cognitive side effects, falls, hospitalization, and death — independently of the underlying disease burden the medications were prescribed for.
How polypharmacy accumulates: • Each specialist adds their own medications without knowing what the others have prescribed • Symptoms caused by one medication get treated with another medication ("prescribing cascade") • Medications that were appropriate years ago stay on the list past the point of benefit • Hospital discharges add medications that should be temporary but become permanent • Over-the-counter and herbal supplements add interactions that nobody on the formal team tracks
The systematic-deprescribing approach: • Annual medication-list review with the PCP or geriatrician • Cross-check against the Beers Criteria (American Geriatrics Society's list of medications high-risk in older adults) • Cross-check against the STOPP/START criteria (a similar evidence-based screening tool) • Ask for each medication: Is this still indicated? Is it still effective? Are the benefits still outweighing risks? Is there a non-medication alternative? • Common deprescribing targets: benzodiazepines (Ativan, Xanax, Klonopin), sleep medications (Ambien, Lunesta), anticholinergics (Benadryl, oxybutynin, amitriptyline), PPIs taken indefinitely without ongoing reflux, statins in patients with limited life expectancy
Family caregiver role: maintain a current single-source medication list (with drug, dose, schedule, prescriber, reason for prescribing). Bring it to every visit. Update it after every discharge. Ask annually: "Can any of these come off?" Most clinicians will reduce a medication list with prompting; few will spontaneously start a deprescribing conversation.
Kintaria's medication-list feature is purpose-built for this — once the list is in one place, it can be shared with every specialist, used at every hospital admission for accurate reconciliation, and reviewed annually for deprescribing opportunities.
Whenever the medication list is being reviewed. "Let's talk about polypharmacy" is the clinician's opening to discuss what can be deprescribed.
Terms families frequently confuse with polypharmacy.
Fall-risk medications are SPECIFIC drugs known to increase fall risk (benzodiazepines, sleep aids, anticholinergics, opioids). Polypharmacy is the broader phenomenon of taking many medications — which includes (but isn't limited to) fall-risk medications. Polypharmacy is a problem even when no individual drug is high-risk; the cumulative interaction burden is what hurts.
Comorbidity = the conditions. Polypharmacy = the resulting medication list. More comorbidities tends to mean more medications, which tends to mean more polypharmacy harm — but the right intervention is sometimes treating fewer conditions aggressively (in the context of frailty + limited life expectancy) rather than treating all of them with separate drugs.
See also: all glossary terms · conditions by name · step-by-step playbooks